Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients - Trial NCT06071065
Access comprehensive clinical trial information for NCT06071065 through Pure Global AI's free database. This phase not specified trial is sponsored by Hamdard University and is currently Recruitment Completed. The study focuses on Chronic Kidney Disease. Target enrollment is 130 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Hamdard University
Timeline & Enrollment
N/A
Sep 22, 2023
Apr 20, 2024
Primary Outcome
Health related Quality of Life,Patients Medication Adherence.
Summary
The purpose of this research study is to evaluate the impact of clinical pharmacist
 interventions on treatment outcomes, health-related quality of life (HRQoL),and medication
 adherence among chronic kidney disease patients.
 
 Pharmacist's intervention aim to answer:
 
 1. How a clinical pharmacist intervention program impact medication adherence in chronic
 kidney disease?
 
 2. To assess how patients' counseling and medication adherence impact patient
 health-related quality of life?
 
 3. How a clinical pharmacist intervention program improves clinical outcomes of chronic
 kidney disease patients?
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06071065
Non-Device Trial